πŸ‡ΊπŸ‡Έ FDA
Patent

US 11285190

CLEC11a is a bone growth agent

granted A61KA61K38/18A61K38/29

Quick answer

US patent 11285190 (CLEC11a is a bone growth agent) held by The Board of Regents of the University of Texas System expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/18, A61K38/29, A61K45/06, A61P